DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo-Reference-Cited by-同舟云学术

DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo

Published:2021-01-01 Issue:1 Volume:38 Page:1415-1424
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Brummelhuis Iris S. G.¹^ORCID,Simons Michiel²,Lindner Lars H.³^ORCID,Kort Simone³,de Jong Sytse⁴,Hossann Martin⁵^ORCID,Witjes J. Alfred¹,Oosterwijk Egbert¹^ORCID

Affiliation:

1. Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

3. Department of Medicine III, University Hospital LMU Munich, Munich, Germany

4. Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

5. Thermosome GmbH, Munich, Germany

Funder

Thermosome

Thermosome GmbH

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2021.1983038

Reference56 articles.

1. GLOBOCAN estimated cancer incidence, mortality, and prevalence worldwide in 2018; [cited 2020 August 26]. Available from: http://globocan.iarc.fr

2. Bladder cancer

3. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

4. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

5. Lessons Learned From 1,000 Neobladders: The 90-Day Complication Rate

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Unveiling FDA-Approved Drugs and Formulations in the Management of Bladder Cancer: A Review;Current Pharmaceutical Biotechnology;2024-05-23

3. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin;Pharmaceutics;2023-03-09

4. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches;Journal of Controlled Release;2022-11

5. Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience;Pharmaceutics;2022-10-11